About
Evvy is unlocking precision women’s healthcare through novel, overlooked female biomarkers — starting with the vaginal microbiome. Backed by leading healthcare investors such as General Catalyst, Left Lane Capital, and LabCorp, the Evvy team includes leading OB/GYNs and vaginal microbiome researchers with decades of experience at organizations like UCSF, Stanford, Harvard, Cleveland Clinic, and more. Evvy is one of the fastest growing women’s health companies in the US — enabling us to deliver innovative, high quality care while scaling novel R&D to unlock a new, data-driven future in women’s health. Evvy’s Vaginal Health Test is the first at-home vaginal microbiome test to use metagenomic sequencing to tell you what’s up down there, why it matters, and what you can do about it. Evvy’s larger platform is the first vaginal healthcare service to bring together state-of-the-art testing, precision clinical care, and 1:1 coaching to give women and people with vaginas the care they deserve. Through this platform, Evvy is building real-world datasets that can transform our understanding of complex female health conditions. Imagine a world where female health is finally understood: where risks are detected early and precisely; conditions are defined with specificity and nuance; and diseases are treated with personalization and care. That’s the world that Evvy is pioneering.
Product
- Value proposition
- Precision vaginal health care through at-home microbiome testing, clinician-reviewed results, personalized plans, and access to targeted treatments.
- Target customers
- Women and people with vaginas seeking vaginal health testing and care
- Pricing
- subscription, per-service (Rx-related care)
Founders
- Priyanka Jain
- Laine Bruzek
- Pita Navarro
Categories
Products
Key features
Technologies
Integrations
Target conditions
Care settings
Certifications
Traction metrics
Competitors
Investors
News
- Evvy: Interview With Co-Founder & CEO Priyanka Jain About The Precision Women’s Health Company · 2025-09-29T17:35:40.000Z
- Startuply.vc: Evvy's 100,000 Vaginal Microbiome Samples Are a Wedge Into Precision Women's Health · 2026-06-13T07:07:17.000Z
- NutraCast: Evvy on connecting the gut, vaginal and urinary health dots · 2025-06-20T05:28:08.000Z
- Evvy Introduces Treatments for Common Vaginal Symptoms - MedCity News · 2024-11-18T22:54:14.000Z
- Evvy Provides Bacterial Vaginosis Symptom Relief, Study Finds - MedCity News · 2025-08-01T22:16:36.000Z
- Evvy maps six subtypes of bacterial vaginosis in 100,000-sample analysis · 2026-02-27T18:43:45.000Z
Browse similar startups
Related startups
- Fourier Health — New York, NY
- Fusia Health — New York, NY
- GeneGenius — New York, NY
- GNOMX Corp. — New York, NY
- HekaHeart — New York, NY
- i-On By Dr. Xi — New York, NY
- FYR Bio — Missoula, MT
- Johnson Medtech — Vandalia, OH
- Orbit Genomics — Boulder, CO
- Quick Test Lab Diagnostics — Oklahoma City, OK
- RESOLVE DIAGNOSTICS LLC — Franklin, TN
- Arborsense (United States) — Ann Arbor, MI
Profile updated Jul 29, 2026. Sources: evvy.com
